Optimizing chimeric antigen receptor (CAR) T cell therapy for adult patients with relapsed or refractory (r/r) acute lymphoblastic leukemia (ALL).Noelle V. Frey, David L. Porter, Elizabeth O. Hexner et al.|Journal of Clinical Oncology|2016Cited by 43